Business EconomyPosted at: Nov 5 2025 12:02AM


Bharat Biotech's Nucelion sets up CRDMO to focus on next generation cell & gene therapy

Hyderabad, Nov 4 (UNI) Nucelion Therapeutics Pvt Ltd, a wholly owned subsidiary of Bharat Biotech International Ltd, established a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies in Hyderabad.
The CRDMO aims to support global life science innovators with high-quality, scalable process development and manufacturing solutions for advanced therapies, indicated for cancers, autoimmune disorders, and rare genetic disorders, the vaccine maker said in a release here today.
Setting up of the wholly-owned subsidiary Nucelion Therapeutics is the part of Bharat Biotech's strategic expansion into the fast-growing field of next-generation Cell and Gene Therapy Contract Research Development and Manufacturing Organisation (CRDMO).
Spread across a 30,000 square foot purpose-built facility in Genome Valley, Nucelion has commissioned a GMP facility capable of developing and manufacturing plasmids, viral and non-viral vectors, cell therapies, and aseptic fill & finish, providing end-to-end services for clients.
The company will offer end-to-end services, from early-stage clinical development to commercial-scale manufacturing, while adhering to international regulatory standards, including those of the FDA and EMA.
Dr. Krishna Ella, Non-Executive Director, Nucelion Therapeutics, said, "The future of pharmaceutical innovation will be biological; CGTs are a key vector. Our vision is to integrate advanced therapy platforms into India's healthcare ecosystem, enabling equitable solutions for complex and rare diseases."
Dr. Raghu Malapaka, Chief Business Officer, Nucelion Therapeutics, said, " Nucelion offers services for the development and manufacturing of plasmid DNA, Viral Vectors, Autologous, and Allogeneic Cell Therapies.
UNI KNR SS
Please log in to get detailed story.
Tags: #Bharat Biotech's Nucelion sets up CRDMO to focus on next generation cell & gene therapy
More News

Bulls back at Dalal Street: Sensex gains over 1,600 points, Rs 9 71 lakh cr added in mcap

12 Jun 2026 | 8:57 PM

New Delhi, Jun 12 (UNI) Indian stock markets on Friday ended with strong buying as the Nifty climbed above the 23,600 mark and the Sensex gained over 1,600 points. The markets gains were aided by easing crude oil prices, a stronger rupee and positive global cues.

see more..

Naxalism eradicated, Bastar 2 0 to drive growth: Chhattisgarh CM

12 Jun 2026 | 7:56 PM

Hyderabad, June 12 (UNI): Chhattisgarh Chief Minister Vishnu Deo Sai on Friday declared that Left-Wing Extremism has been effectively eliminated from the state, marking the end of a decades-long Maoist insurgency and paving the way for accelerated development in the Bastar region.

see more..

12 Jun 2026 | 6:35 PM

New Delhi, June 12 (UNI): Consumer Price Inflation (CPI) rose to 3.9 percent in May from 3.5 percent in April, led by broad-based pressures from food and non-food segments, with the latter contributing more significantly, said Dipti Deshpande, Principal Economist of Crisil Ltd.

see more..

Indian REITs Association hosts first Investor awareness programme in Lucknow

12 Jun 2026 | 5:31 PM

Lucknow, Jun 12(UNI) The Indian REITs Association (IRA) on Friday organised its first REIT awareness programme in Lucknow to educate investors about Real Estate Investment Trusts (REITs) and their potential as an investment option.
The programme forms part of IRA's ongoing efforts to increase awareness of REITs and promote a better understanding of this emerging asset class among investors.

see more..

Retail inflation rose to 3 93 percent in May

12 Jun 2026 | 4:57 PM

New Delhi, June 12 (UNI) India's retail inflation rose to 3.93 percent in May compared to 3.48 percent in April, government data said.

see more..